2 Result(s)
within
P Thuss-Patience
Biomedicine
-
Article
Open AccessIrinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
To assess the response rate and the tolerance of irinotecan as first-line therapy, 40 patients with metastatic gastric cancer received irinotecan 350 mg m−2 every 3 weeks administered as a 30 min infusion. Among ...
-
Article
Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity
Two patients with proven 5-fluorouracil (5-FU)-associated cardiotoxicity were treated with the specific thymidylate synthase inhibitor raltitrexed safely, without evidence of cardiotoxicity. Raltitrexed might ...
